Main

processing priority

3

site type

0 (generic, awaiting analysis)

review version

11

html import

27 (unknown)

Events

first seen date

2024-08-07 15:01:19

expired found date

-

created at

2024-08-07 15:01:18

updated at

2024-11-21 05:56:25

Domain name statistics

length

11

crc

65483

tld

156

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

0

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

9

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

2024-12-05 05:56:28

Server

server bits

server ip

-

Mainpage statistics

mp import status

27

mp rejected date

-

mp saved date

-

mp size orig

14927

mp size raw text

1437

mp inner links count

9

mp inner links status

10 (links queued, awaiting import)

Open Graph

title

description

江苏EBET易博医药股份有限公司★★是一家从事创新和高品质药品研制及推广的民族制药企业,已发展成为国内知名的抗肿瘤药、手术用药和影像介入产品的供应商。2020年,EBET易博医药入选全球投行Torreya公布的全球1000强药企榜单,位列第21位。在美国制药经理人杂志(PharmExec)公布的2021年全球制药企业TOP50榜单中,EBET易博医药排名连续三年攀升,位列第38位

image

site name

author

updated

2026-02-17 20:46:29

raw text

EBET易博_EBET易博-官方网站 watnohc hjhpbhy zjlyfru hyiqdmi vqytvjj fimoqkv xuekdqq bwfzfqk dwbmirp heudhcv arepmxf gnhglqg wgfefhg kchvsoh ncttehu EBET易博 科技为本 为人类创造健康生活 PROMOTE A HEALTHIER LIFE FOR HUMANKIND THROUGH ADVANCEMENTS IN SCIENCE. 科技为本 为人类创造健康生活 PROMOTE A HEALTHIER LIFE FOR HUMANKIND THROUGH ADVANCEMENTS IN SCIENCE. 锐意创新 攻坚克难造;颊 BENEFIT THE PATIENTS WITH HIGH-QUALITY MEDICATION AS WE DETERMINED TO INNOVATE. 锐意创新 攻坚克难造;颊 BENEFIT THE PATIENTS WITH HIGH-QUALITY MEDICATION AS WE DETERMINED TO INNOVATE. 汇智全球 打造跨国制药集团 BUILD A LEADING GLOBAL BIOPHARMACEUTICAL GROUP TO SERVE MORE. 汇智全球 打造跨国制药集团 BUILD A LEADING GLOBAL BIOPHARMACEUTICAL GROUP TO SERVE MORE. 勇于担当 积极履行社会责任 FULFILL SOCIAL RESPONSIBILITIES THROUGH ACCOUNTABLE ACTIONS. 勇于担当 积极履行社会责任 FULFILL SOCIAL RESPONSIBILITIES THROUGH ACCOUNTABLE ACTIONS. 新闻 动态 了解更多 > > 新闻速递 EBET易博医药PD-L1抑制剂阿得贝利单抗与HER2 ADC SHR-A1811联合治疗乳腺癌获批临床 焦点新闻 EBET易博医药荣登2023年江苏制造业企业发明专...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Other [en] (231)

index version

2025123101

spam phrases

0

Text statistics

text nonlatin

374

text cyrillic

0

text characters

1050

text words

166

text unique words

110

text lines

93

text sentences

9

text paragraphs

0

text words per sentence

18

text matched phrases

0

text matched dictionaries

0

RSS

rss path

rss status

0 (new)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap path

sitemap status

0 (new)

sitemap review version

1

sitemap urls count

0

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

-

sitemap process date

-

sitemap first import date

-

sitemap last import date

-